DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0018784 | Sensorineural Hearing Loss (disorder) | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0085580 | Essential Hypertension | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0376359 | Gronblad-Strandberg Syndrome | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0022658 | Kidney Diseases | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0018818 | Ventricular Septal Defects | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0085669 | Acute leukemia | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C1561643 | Chronic Kidney Diseases | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0042769 | Virus Diseases | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0026267 | Mitral Valve Prolapse Syndrome | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C1535939 | Pneumocystis jiroveci pneumonia | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0002418 | Amblyopia | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0030567 | Parkinson Disease | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0020433 | Hyperbilirubinemia | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C0023890 | Liver Cirrhosis | GLT8D2 | 83468 | glycosyltransferase 8 domain containing 2 | Q9H1C3 |
C0019196 | Hepatitis C | GLT8D2 | 83468 | glycosyltransferase 8 domain containing 2 | Q9H1C3 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | SLC35B3 | 51000 | solute carrier family 35 member B3 | Q9H1N7 |
C0024623 | Malignant neoplasm of stomach | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0027651 | Neoplasms | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0010674 | Cystic Fibrosis | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0017205 | Gaucher Disease | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0699791 | Stomach Carcinoma | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C1961835 | Gaucher Disease, Type 1 | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0011854 | Diabetes Mellitus, Insulin-Dependent | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0740858 | Substance abuse problem | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0264408 | Childhood asthma | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024